Atrion Corp

ATRI-Q

Analysis and Opinions about ATRI-Q

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
July 24, 2020
(A Top Pick Jul 29/19, Down 17%) They are in medical devices -- cardiac, eyes and fluid delivery devices. Elective surgeries have declined, but fluid delivery has continued to do well. They have been buying back shares around $630 per share, so there is good support here.
Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
July 24, 2020
(A Top Pick Jul 29/19, Down 17%) They are in medical devices -- cardiac, eyes and fluid delivery devices. Elective surgeries have declined, but fluid delivery has continued to do well. They have been buying back shares around $630 per share, so there is good support here.
BUY WEAKNESS
BUY WEAKNESS
January 13, 2020
It is a medical device company. It is potentially an acquisition target. It has had a decent run. It is an interesting company. It is not a buy but could be in a bit more of a sell off.
Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
January 13, 2020
It is a medical device company. It is potentially an acquisition target. It has had a decent run. It is an interesting company. It is not a buy but could be in a bit more of a sell off.
PARTIAL BUY
PARTIAL BUY
December 30, 2019
A small cap medical device company, only US$400 million. They're good at what they do, but it's volatile. Use limit orders. He's owned this since $100/share, and has bought on pullbacks. They have new products in the pipe, but there was a slowdown in the supply chain recently. Dividend is growing by 10-15%. Organic revenue growth around 5%. Start with a half-position with the current toppy market.
Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
December 30, 2019
A small cap medical device company, only US$400 million. They're good at what they do, but it's volatile. Use limit orders. He's owned this since $100/share, and has bought on pullbacks. They have new products in the pipe, but there was a slowdown in the supply chain recently. Dividend is growing by 10-15%. Organic revenue growth around 5%. Start with a half-position with the current toppy market.
PAST TOP PICK
PAST TOP PICK
October 28, 2019
(A Top Pick Jul 29/19, Up 10%) A small Texas company. Not in any ETFs, so this will avoid an ETF sell-off when markets panic. They are in health care. They've been very acquisitive.
Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
October 28, 2019
(A Top Pick Jul 29/19, Up 10%) A small Texas company. Not in any ETFs, so this will avoid an ETF sell-off when markets panic. They are in health care. They've been very acquisitive.
TOP PICK
TOP PICK
July 29, 2019
Great cash flow with little debt. Cash is his key metric. When the Russell was down 12% in 2018, ATRI was up 18%. Great long-term hold. (no price target)
Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
July 29, 2019
Great cash flow with little debt. Cash is his key metric. When the Russell was down 12% in 2018, ATRI was up 18%. Great long-term hold. (no price target)
COMMENT
COMMENT
January 11, 2018

Small caps tend to be less liquid and therefore may have higher betas, although this one is low at 6.1, because it doesn't trade a lot. It makes all kinds of medical devices that none of the big guys want to manufacture. A good entry point would be around $50. This is one you want to hold for the long run.

Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
January 11, 2018

Small caps tend to be less liquid and therefore may have higher betas, although this one is low at 6.1, because it doesn't trade a lot. It makes all kinds of medical devices that none of the big guys want to manufacture. A good entry point would be around $50. This is one you want to hold for the long run.

PAST TOP PICK
PAST TOP PICK
December 15, 2016

(A Top Pick Jan 15/16. Up 44.32%.) A tiny little company out of Texas that makes things in the healthcare sector that nobody else wants to create, such as little catheters, IV tubes, cases for contact lenses, etc. His fear is that this company could get bought out because the CEO is getting into his 60s, and succession would be a risk. He wouldn’t buy at this price as it is a little overpriced. Buy on weakness.

Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
December 15, 2016

(A Top Pick Jan 15/16. Up 44.32%.) A tiny little company out of Texas that makes things in the healthcare sector that nobody else wants to create, such as little catheters, IV tubes, cases for contact lenses, etc. His fear is that this company could get bought out because the CEO is getting into his 60s, and succession would be a risk. He wouldn’t buy at this price as it is a little overpriced. Buy on weakness.

PAST TOP PICK
PAST TOP PICK
June 7, 2016

(A Top Pick April 4/16. (Actually Jan 15/16.) Up 0.65%.) A little, small medical device company that handles products that larger companies don’t want to be bothered with. It continues to grow very well in the little niches that nobody else wants to do. The dividend has been growing roughly at a 20% clip. Earnings are supposed to be between $15 and $20.

Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
June 7, 2016

(A Top Pick April 4/16. (Actually Jan 15/16.) Up 0.65%.) A little, small medical device company that handles products that larger companies don’t want to be bothered with. It continues to grow very well in the little niches that nobody else wants to do. The dividend has been growing roughly at a 20% clip. Earnings are supposed to be between $15 and $20.

PAST TOP PICK
PAST TOP PICK
April 4, 2016

(Top Pick Jan 15/16, Up 10.30%) Small company that makes vascular clamps and pull tags on life vest. Long term growth over the last 15-20 years. No one else makes these clips. They make good margins.

Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
April 4, 2016

(Top Pick Jan 15/16, Up 10.30%) Small company that makes vascular clamps and pull tags on life vest. Long term growth over the last 15-20 years. No one else makes these clips. They make good margins.

TOP PICK
TOP PICK
January 15, 2016

A tiny healthcare company that no US brokerage analyst covers. A quiet stock that small investors can buy. Not very liquid, but they have been around for many, many years. They make widgets in operating rooms for open-heart surgery, and the machines that moves medicine and blood flow into the heart while the surgery is going on. Growth about 7%-8% a year. Dividend yield of 1.01%.

Show full opinionHide full opinion
Atrion Corp (ATRI-Q)
January 15, 2016

A tiny healthcare company that no US brokerage analyst covers. A quiet stock that small investors can buy. Not very liquid, but they have been around for many, many years. They make widgets in operating rooms for open-heart surgery, and the machines that moves medicine and blood flow into the heart while the surgery is going on. Growth about 7%-8% a year. Dividend yield of 1.01%.

Showing 1 to 10 of 10 entries
  • «
  • 1
  • »

Atrion Corp(ATRI-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Atrion Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Atrion Corp(ATRI-Q) Frequently Asked Questions

What is Atrion Corp stock symbol?

Atrion Corp is a American stock, trading under the symbol ATRI-Q on the NASDAQ (ATRI). It is usually referred to as NASDAQ:ATRI or ATRI-Q

Is Atrion Corp a buy or a sell?

In the last year, 4 stock analysts published opinions about ATRI-Q. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is PAST TOP PICK. Read the latest stock experts' ratings for Atrion Corp.

Is Atrion Corp a good investment or a top pick?

Atrion Corp was recommended as a Top Pick by Brett Girard, CPA, CA, CFA on 2020-07-24. Read the latest stock experts ratings for Atrion Corp.

Why is Atrion Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Atrion Corp worth watching?

4 stock analysts on Stockchase covered Atrion Corp In the last year. It is a trending stock that is worth watching.

What is Atrion Corp stock price?

On 2020-08-14, Atrion Corp (ATRI-Q) stock closed at a price of $648.2.